The dual function of autophagy in doxorubicin-induced cardiotoxicity: Mechanism and natural products

IF 15.7 1区 医学 Q1 ONCOLOGY Seminars in cancer biology Pub Date : 2025-02-01 DOI:10.1016/j.semcancer.2025.01.004
Nannan Tan , Hanwen Luo , Weili Li , Guanjing Ling , Yan Wei , Wei Wang , Yong Wang
{"title":"The dual function of autophagy in doxorubicin-induced cardiotoxicity: Mechanism and natural products","authors":"Nannan Tan ,&nbsp;Hanwen Luo ,&nbsp;Weili Li ,&nbsp;Guanjing Ling ,&nbsp;Yan Wei ,&nbsp;Wei Wang ,&nbsp;Yong Wang","doi":"10.1016/j.semcancer.2025.01.004","DOIUrl":null,"url":null,"abstract":"<div><div>Doxorubicin (DOX) is an anthracycline antitumor drug discovered in 1969, which can care for leukemia, breast cancer, lymphoma, and sarcoma. However, cardiotoxicity induced by DOX seriously limits its clinical value. The etiopathogenesis and therapeutic strategies are not unified. Autophagy is a critical mechanism in the progression of DOX-induced cardiotoxicity (DIC), autophagy intervention is a potential therapeutic strategy for DIC. Natural product has been considered as a complementary and alternative approach to treat cardiovascular disease. In this review, we summarize the pathology of autophagy in DIC and the natural products for DIC therapy.</div></div>","PeriodicalId":21594,"journal":{"name":"Seminars in cancer biology","volume":"109 ","pages":"Pages 83-90"},"PeriodicalIF":15.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in cancer biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1044579X25000100","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Doxorubicin (DOX) is an anthracycline antitumor drug discovered in 1969, which can care for leukemia, breast cancer, lymphoma, and sarcoma. However, cardiotoxicity induced by DOX seriously limits its clinical value. The etiopathogenesis and therapeutic strategies are not unified. Autophagy is a critical mechanism in the progression of DOX-induced cardiotoxicity (DIC), autophagy intervention is a potential therapeutic strategy for DIC. Natural product has been considered as a complementary and alternative approach to treat cardiovascular disease. In this review, we summarize the pathology of autophagy in DIC and the natural products for DIC therapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自噬在阿霉素诱导的心脏毒性中的双重功能:机制和天然产物。
多柔比星(DOX)是1969年发现的一种蒽环类抗肿瘤药物,可治疗白血病、乳腺癌、淋巴瘤和肉瘤。然而,DOX的心脏毒性严重限制了其临床应用价值。发病机制和治疗策略不统一。自噬是dox诱导的心脏毒性(DIC)发生的重要机制,自噬干预是治疗DIC的一种潜在的治疗策略。天然产物已被认为是治疗心血管疾病的补充和替代方法。本文就DIC的自噬病理及治疗DIC的天然产物作一综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Seminars in cancer biology
Seminars in cancer biology 医学-肿瘤学
CiteScore
26.80
自引率
4.10%
发文量
347
审稿时长
15.1 weeks
期刊介绍: Seminars in Cancer Biology (YSCBI) is a specialized review journal that focuses on the field of molecular oncology. Its primary objective is to keep scientists up-to-date with the latest developments in this field. The journal adopts a thematic approach, dedicating each issue to an important topic of interest to cancer biologists. These topics cover a range of research areas, including the underlying genetic and molecular causes of cellular transformation and cancer, as well as the molecular basis of potential therapies. To ensure the highest quality and expertise, every issue is supervised by a guest editor or editors who are internationally recognized experts in the respective field. Each issue features approximately eight to twelve authoritative invited reviews that cover various aspects of the chosen subject area. The ultimate goal of each issue of YSCBI is to offer a cohesive, easily comprehensible, and engaging overview of the selected topic. The journal strives to provide scientists with a coordinated and lively examination of the latest developments in the field of molecular oncology.
期刊最新文献
Cancer therapy-related cardiovascular toxicity: Current progress and future perspectives. Microbiome-modulated immunotherapy in oncology: Current applications and future prospects Lipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease Integrative spatial omics and artificial intelligence: transforming cancer research with omics data and AI Lipid dysregulation in renal cancer: Drivers of tumor growth and determinants of treatment-induced toxicity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1